Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts

SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process trans...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Axel Schmidt, Heribert Helgers, Florian Lukas Vetter, Alex Juckers, Jochen Strube
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/36df35f292794daaa354e627e9a63b18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:36df35f292794daaa354e627e9a63b18
record_format dspace
spelling oai:doaj.org-article:36df35f292794daaa354e627e9a63b182021-11-25T18:49:58ZFast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts10.3390/pr91118742227-9717https://doaj.org/article/36df35f292794daaa354e627e9a63b182021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9717/9/11/1874https://doaj.org/toc/2227-9717SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process transfer for manufacturing capacity multiplication, a reduction in out-of-specification batch failures, qualified personal training for faster validation and efficient operation, optimal utilization of scarce buffers and chemicals and speed-up of product release by continuous manufacturing. In this work, three manufacturing concepts for mRNA-based vaccines are evaluated: Batch, full-continuous and semi-continuous. Technical transfer from batch single-use to semi-continuous stainless-steel, i.e., plasmid deoxyribonucleic acid (pDNA) in batch and mRNA in continuous operation mode, is recommended, in order to gain: faster plant commissioning and start-up times of about 8–12 months and a rise in dose number by a factor of about 30 per year, with almost identical efforts in capital expenditures (CAPEX) and personnel resources, which are the dominant bottlenecks at the moment, at about 25% lower operating expenses (OPEX). Consumables are also reduceable by a factor of 6 as outcome of this study. Further optimization potential is seen at consequent digital twin and PAT (Process Analytical Technology) concept integration as key-enabling technologies towards autonomous operation including real-time release-testing.Axel SchmidtHeribert HelgersFlorian Lukas VetterAlex JuckersJochen StrubeMDPI AGarticlemRNApDNASARS-COVID-19vaccinesdigital twinprocess analytical technologyChemical technologyTP1-1185ChemistryQD1-999ENProcesses, Vol 9, Iss 1874, p 1874 (2021)
institution DOAJ
collection DOAJ
language EN
topic mRNA
pDNA
SARS-COVID-19
vaccines
digital twin
process analytical technology
Chemical technology
TP1-1185
Chemistry
QD1-999
spellingShingle mRNA
pDNA
SARS-COVID-19
vaccines
digital twin
process analytical technology
Chemical technology
TP1-1185
Chemistry
QD1-999
Axel Schmidt
Heribert Helgers
Florian Lukas Vetter
Alex Juckers
Jochen Strube
Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
description SARS-COVID-19 vaccine supply for the total worldwide population has a bottleneck in manufacturing capacity. Assessment of existing messenger ribonucleic acid (mRNA) vaccine processing shows a need for digital twins enabled by process analytical technology approaches in order to improve process transfer for manufacturing capacity multiplication, a reduction in out-of-specification batch failures, qualified personal training for faster validation and efficient operation, optimal utilization of scarce buffers and chemicals and speed-up of product release by continuous manufacturing. In this work, three manufacturing concepts for mRNA-based vaccines are evaluated: Batch, full-continuous and semi-continuous. Technical transfer from batch single-use to semi-continuous stainless-steel, i.e., plasmid deoxyribonucleic acid (pDNA) in batch and mRNA in continuous operation mode, is recommended, in order to gain: faster plant commissioning and start-up times of about 8–12 months and a rise in dose number by a factor of about 30 per year, with almost identical efforts in capital expenditures (CAPEX) and personnel resources, which are the dominant bottlenecks at the moment, at about 25% lower operating expenses (OPEX). Consumables are also reduceable by a factor of 6 as outcome of this study. Further optimization potential is seen at consequent digital twin and PAT (Process Analytical Technology) concept integration as key-enabling technologies towards autonomous operation including real-time release-testing.
format article
author Axel Schmidt
Heribert Helgers
Florian Lukas Vetter
Alex Juckers
Jochen Strube
author_facet Axel Schmidt
Heribert Helgers
Florian Lukas Vetter
Alex Juckers
Jochen Strube
author_sort Axel Schmidt
title Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
title_short Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
title_full Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
title_fullStr Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
title_full_unstemmed Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts
title_sort fast and flexible mrna vaccine manufacturing as a solution to pandemic situations by adopting chemical engineering good practice—continuous autonomous operation in stainless steel equipment concepts
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/36df35f292794daaa354e627e9a63b18
work_keys_str_mv AT axelschmidt fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts
AT heriberthelgers fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts
AT florianlukasvetter fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts
AT alexjuckers fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts
AT jochenstrube fastandflexiblemrnavaccinemanufacturingasasolutiontopandemicsituationsbyadoptingchemicalengineeringgoodpracticecontinuousautonomousoperationinstainlesssteelequipmentconcepts
_version_ 1718410640796680192